本文選題：血管瘤 + 栓塞��； 參考：《中國(guó)介入影像與治療學(xué)》2017年10期

【摘要】：目的探討經(jīng)導(dǎo)管動(dòng)脈硬化栓塞(TASE)聯(lián)合口服普萘洛爾治療普通嬰兒巨大血管瘤的臨床療效與安全性。方法對(duì)76例普通嬰兒巨大血管瘤患兒行TASE聯(lián)合口服普萘洛爾治療,于末次治療后進(jìn)行療效評(píng)價(jià),分析并發(fā)癥發(fā)生情況。結(jié)果對(duì)76例患兒共行TASE共95例次,穿刺技術(shù)成功率為100%(95/95)。76例患兒中,Ⅰ級(jí)預(yù)后6例(6/76,7.90%),Ⅱ級(jí)19例(19/76,25.00%),Ⅲ級(jí)23例(23/76,30.26%),Ⅳ級(jí)28例(28/76,36.84%),總有效率100%(76/76)。隨訪發(fā)現(xiàn)療效穩(wěn)定,無(wú)嚴(yán)重并發(fā)癥發(fā)生。結(jié)論 TASE聯(lián)合口服普萘洛爾治療嬰兒巨大血管瘤療效確切,且創(chuàng)傷小、并發(fā)癥少。
[Abstract]:Objective to evaluate the efficacy and safety of transcatheter arterial embolization (TASE) combined with oral propranolol in the treatment of giant hemangioma in infants. Methods 76 cases of normal infants with giant hemangioma were treated with TASE combined with oral propranolol. Results there were 95 cases of tase in 76 cases. The success rate of puncture technique was 100% (95 / 95) .76 cases, the prognosis of grade 鈪，

本文編號(hào)：2102412